Guest Editor's Memo

Advances in Pulmonary Hypertension

¹ 

关键词: Cardiology;    WHO Group 1- Pulmonary Arterial Hypertension;    WHO Group 2- PH owing to left heart disease (left heart failure);    diastolic dysfunction;    nitric oxide;    Diuretics;    Indicators of diastolic dysfunction;    Cardiac Output;    Preserved ejection fraction;    endothelial dysfunction;    Classification;    Epidemiology;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

Pulmonary hypertension (PH) associated with left heart disease is the single most common form of PH we encounter in clinical practice today. Divided into 3 categories – systolic dysfunction, diastolic dysfunction, valvular disease – the presence of PH is well recognized to portend worse outcome across the spectrum of cardiac disorders. PH associated with diastolic dysfunction presents unique challenges for clinicians, as at first glance it shares many similar features with pulmonary arterial hypertension (PAH). Furthermore, the incidence of PH with diastolic dysfunction is in sharp rise, in parallel with the aging population and increase in incidence of obesity. It is no wonder that I often hear my referring colleagues comment, “All of my patients have PH. It has become an epidemic!”.

【 授权许可】

All Rights reserved